CRITICAL PATH INSTITUTE ANNOUNCES NEW CEO

Tucson, Arizona, February 1, 2012– Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chief executive officer. Dr. Compton takes over for Dr. Raymond L. Woosley, C-Path’s founder, who last year announced his intention to step down as President/CEO, and asked the Board of Directors to begin a search for his successor.Continue reading

Ernst and Young Life Sciences Report for January 2012

Understanding the issues facing your company or industry is critical to anticipating and alleviating business risk. To assist you, Ernst and Young offers two Smoke Detector® Reports that can help you quickly identify new legislative, regulatory and legal news affecting your business. One report monitors the life sciences industry and the other focuses on corporate compliance.

Continue reading

From Discovery to Patient: The Journey of a New Drug

The development of a new drug is a long, complicated process involving up to 15 years of research and, in many cases, hundreds of millions of dollars. There are two distinct processes that every drug must go through before reaching the general patient population and treating a specific disease – Drug Discovery and Drug Development.Continue reading